HomeNewsWorldCOVID-19 | We are closer to beginning than end of pandemic, says epidemiologist Larry Brilliant

COVID-19 | We are closer to beginning than end of pandemic, says epidemiologist Larry Brilliant

The major worry about the Delta variant is not that it makes people sicker, but that it spreads far more easily from person to person, increasing infections and hospitalisations among the unvaccinated.

August 09, 2021 / 15:08 IST
Story continues below Advertisement

Larry Brilliant, an epidemiologist who was part of the World Health Organisation’s (WHO) team that helped eradicate smallpox, has said that the COVID-19 pandemic isn’t going to end soon.

“I think we’re closer to the beginning than we are to the end [of the pandemic], and that’s not because the variant that we’re looking at right now is going to last that long,” Brilliant told CNBC.

Story continues below Advertisement

He added that unless everyone in over 200 plus countries is vaccinated, there will be new variants predicting that coronavirus will become “forever virus” like influenza.

Daily new COVID-19 cases have climbed to a six-month high in the United States, with more than 100,000 infections reported nationwide as the Delta variant ravaged Florida and other states with lower vaccination rates.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show